UKVAISTA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 463,410 | 502,757 | 554,707 | 583,707 | 616,478 | 628,472 | 637,539 | 894,912 |
| Profit before tax | 25,923 | 31,472 | 82,975 | 57,507 | 85,332 | 75,614 | 72,749 | 93,562 |
| Net profit | 22,034 | 26,751 | 70,264 | 48,735 | 72,532 | 64,272 | 61,837 | 78,592 |
| Equity | 321,968 | 308,719 | 378,983 | 342,718 | 379,729 | 423,843 | 445,680 | 474,273 |
| Liabilities | 33,996 | 32,062 | 42,272 | 42,471 | 45,729 | 49,003 | 44,031 | 44,920 |
| Non-current assets | 29,957 | 27,667 | 9,264 | 52,949 | 45,793 | 37,009 | 27,744 | 18,517 |
| Current assets | 326,007 | 313,114 | 411,991 | 332,240 | 379,665 | 435,837 | 461,967 | 500,676 |
| Total assets | 355,964 | 340,781 | 421,255 | 385,189 | 425,458 | 472,846 | 489,711 | 519,193 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 68,185 | 68,435 | 83,093 |
| Social insurance contributions | - | - | - | - | - | 19,008 | 19,911 | 22,702 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.6% | +8.5% | +10.3% | +5.2% | +5.6% | +1.9% | +1.4% | +40.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.2% | 7.8% | 16.7% | 12.7% | 17.0% | 13.6% | 12.6% | 15.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.8% | 8.7% | 18.5% | 14.2% | 19.1% | 15.2% | 13.9% | 16.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.8% | 5.3% | 12.7% | 8.3% | 11.8% | 10.2% | 9.7% | 8.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.6% | 6.3% | 15.0% | 9.9% | 13.8% | 12.0% | 11.4% | 10.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 43,445 | 50,276 | 55,471 | 62,540 | 68,498 | 71,148 | 70,838 | 93,382 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
UKVAISTA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-23 | 2024-05-12 | 0.02 |
| 2024-04-16 | 2024-04-22 | 0.01 |
| 2024-03-18 | 2024-04-10 | 0.01 |
| 2024-01-16 | 2024-02-14 | 0.60 |
| 2023-12-18 | 2024-01-11 | 0.60 |
| 2021-10-18 | 2021-10-24 | 0.80 |
| 2021-09-27 | 2021-10-13 | 0.80 |
UKVAISTA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
UKVAISTA, UAB (code 183217118) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €894.9K, up 40.4% year on year and 42.4% over two years. Net profit increased to €78.6K in 2025 from €61.8K in 2024 and €64.3K in 2023, while profit margin remained positive but narrowed from 10.2% in 2023 to 9.7% in 2024 and 8.8% in 2025. Total assets rose to €519.2K in 2025 from €489.7K a year earlier and €472.8K in 2023. Equity also increased steadily to €474.3K, while liabilities stayed low at €44.9K, resulting in an equity ratio of 91.3% and a debt-to-equity ratio of 0.09. The balance sheet is dominated by short-term assets, which reached €500.7K in 2025, compared with €18.5K in long-term assets. Profitability and efficiency remained solid, with ROE at 16.6%, ROA at 15.1%, and asset turnover at 1.72x in 2025. Revenue per employee was €99.4K, and profit per employee was €8.7K.